1. Home
  2. ELUT vs ECOR Comparison

ELUT vs ECOR Comparison

Compare ELUT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • ECOR
  • Stock Information
  • Founded
  • ELUT 2015
  • ECOR 2005
  • Country
  • ELUT United States
  • ECOR United States
  • Employees
  • ELUT N/A
  • ECOR N/A
  • Industry
  • ELUT Medical Specialities
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ELUT Health Care
  • ECOR Health Care
  • Exchange
  • ELUT Nasdaq
  • ECOR Nasdaq
  • Market Cap
  • ELUT 38.2M
  • ECOR 40.0M
  • IPO Year
  • ELUT 2020
  • ECOR 2018
  • Fundamental
  • Price
  • ELUT $0.91
  • ECOR $5.04
  • Analyst Decision
  • ELUT Strong Buy
  • ECOR Strong Buy
  • Analyst Count
  • ELUT 2
  • ECOR 2
  • Target Price
  • ELUT $7.00
  • ECOR $25.50
  • AVG Volume (30 Days)
  • ELUT 286.4K
  • ECOR 41.6K
  • Earning Date
  • ELUT 11-06-2025
  • ECOR 11-05-2025
  • Dividend Yield
  • ELUT N/A
  • ECOR N/A
  • EPS Growth
  • ELUT N/A
  • ECOR N/A
  • EPS
  • ELUT N/A
  • ECOR N/A
  • Revenue
  • ELUT $23,683,000.00
  • ECOR $27,700,000.00
  • Revenue This Year
  • ELUT $1.90
  • ECOR $23.74
  • Revenue Next Year
  • ELUT $6.37
  • ECOR $42.02
  • P/E Ratio
  • ELUT N/A
  • ECOR N/A
  • Revenue Growth
  • ELUT N/A
  • ECOR 30.16
  • 52 Week Low
  • ELUT $0.85
  • ECOR $4.16
  • 52 Week High
  • ELUT $5.12
  • ECOR $19.49
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 32.90
  • ECOR 50.60
  • Support Level
  • ELUT $0.89
  • ECOR $4.88
  • Resistance Level
  • ELUT $0.92
  • ECOR $5.19
  • Average True Range (ATR)
  • ELUT 0.03
  • ECOR 0.23
  • MACD
  • ELUT 0.03
  • ECOR 0.01
  • Stochastic Oscillator
  • ELUT 53.10
  • ECOR 59.91

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: